Tianchen Biological
Latest round
- Series C
Last raised
- Jun 2025
Total raised
- $43M
Investors
- 14
About Tianchen Biological
Established in 2020 and based in Suzhou, China, Tianchen Biological is a biomedical company that specializes in the research and development of differentiated macromolecular antibodies in the field of autoimmune diseases. In March 2021, the company's products LP-003 and LP-001 received clinical approval from the State Drug Administration. Dr. Niachao Sun of the company, is the founder of Tanox, USA, and Dr.D. in Biology. The company has cooperated with RxVision. The company also established a research and development center in Shanghai. The technology platforms developed by the company include antibody discovery platform, antibody engineering platform and process development platform. Antibody engineering platform includes the modification of recoverable antibodies, modification of CHO display platform and other functions. The pipelines of the company include LP-003, LP-001, LP-005, LP-006, and other pipelines, which can be used in ophthalmology, nephrology, hematology. The company also provides antibody testing services. The company’s revenue is generated by providing large molecule antibodies.
Who invested in Tianchen Biological
14 investors across 5 rounds
See all investors in Tianchen Biological
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tianchen Biological
Who invested in Tianchen Biological?
Tianchen Biological has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tianchen Biological raised?
Tianchen Biological has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Tianchen Biological last raise money?
Tianchen Biological's most recent round on record is a Series C, in Jun 2025.
What does Tianchen Biological do?
Established in 2020 and based in Suzhou, China, Tianchen Biological is a biomedical company that specializes in the research and development of differentiated macromolecular antibodies in the field of autoimmune diseases.
Where is Tianchen Biological headquartered?
Tianchen Biological is headquartered in Changshu, China.
Which VCs invest in companies like Tianchen Biological?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Tianchen Biological's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Tianchen Biological? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.